nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CYP2C19—Cholecalciferol—psoriasis	0.0327	0.13	CbGbCtD
Topiramate—CYP3A4—Calcitriol—psoriasis	0.0307	0.122	CbGbCtD
Topiramate—CYP3A4—Methoxsalen—psoriasis	0.0238	0.095	CbGbCtD
Topiramate—CYP2C19—Prednisone—psoriasis	0.0226	0.0902	CbGbCtD
Topiramate—CYP2C19—Cyclosporine—psoriasis	0.0215	0.0855	CbGbCtD
Topiramate—CYP3A4—Cholecalciferol—psoriasis	0.0158	0.0629	CbGbCtD
Topiramate—CYP2C19—Dexamethasone—psoriasis	0.0141	0.0563	CbGbCtD
Topiramate—CYP3A4—Mycophenolate mofetil—psoriasis	0.0137	0.0545	CbGbCtD
Topiramate—CYP3A4—Triamcinolone—psoriasis	0.0137	0.0545	CbGbCtD
Topiramate—CYP3A4—Betamethasone—psoriasis	0.0117	0.0468	CbGbCtD
Topiramate—CYP3A4—Prednisolone—psoriasis	0.0116	0.0462	CbGbCtD
Topiramate—CYP3A4—Hydrocortisone—psoriasis	0.011	0.0438	CbGbCtD
Topiramate—CYP3A4—Prednisone—psoriasis	0.0109	0.0436	CbGbCtD
Topiramate—CYP3A4—Cyclosporine—psoriasis	0.0104	0.0413	CbGbCtD
Topiramate—CYP3A4—Dexamethasone—psoriasis	0.00683	0.0272	CbGbCtD
Topiramate—Discomfort—Dexamethasone—psoriasis	0.000119	0.000158	CcSEcCtD
Topiramate—Dyspepsia—Hydrocortisone—psoriasis	0.000118	0.000158	CcSEcCtD
Topiramate—Haemoglobin—Methotrexate—psoriasis	0.000118	0.000158	CcSEcCtD
Topiramate—Rash—Mycophenolic acid—psoriasis	0.000118	0.000158	CcSEcCtD
Topiramate—Dermatitis—Mycophenolic acid—psoriasis	0.000118	0.000157	CcSEcCtD
Topiramate—Pain—Prednisolone—psoriasis	0.000118	0.000157	CcSEcCtD
Topiramate—Haemorrhage—Methotrexate—psoriasis	0.000118	0.000157	CcSEcCtD
Topiramate—Hepatitis—Methotrexate—psoriasis	0.000118	0.000157	CcSEcCtD
Topiramate—Urticaria—Mycophenolate mofetil—psoriasis	0.000117	0.000157	CcSEcCtD
Topiramate—Headache—Mycophenolic acid—psoriasis	0.000117	0.000157	CcSEcCtD
Topiramate—Decreased appetite—Hydrocortisone—psoriasis	0.000117	0.000156	CcSEcCtD
Topiramate—Pharyngitis—Methotrexate—psoriasis	0.000117	0.000156	CcSEcCtD
Topiramate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000117	0.000156	CcSEcCtD
Topiramate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000117	0.000156	CcSEcCtD
Topiramate—Urinary tract disorder—Methotrexate—psoriasis	0.000116	0.000155	CcSEcCtD
Topiramate—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000116	0.000155	CcSEcCtD
Topiramate—Fatigue—Hydrocortisone—psoriasis	0.000116	0.000155	CcSEcCtD
Topiramate—Vision blurred—Prednisone—psoriasis	0.000116	0.000154	CcSEcCtD
Topiramate—Urethral disorder—Methotrexate—psoriasis	0.000115	0.000154	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000115	0.000154	CcSEcCtD
Topiramate—Pain—Hydrocortisone—psoriasis	0.000115	0.000154	CcSEcCtD
Topiramate—Oedema—Betamethasone—psoriasis	0.000115	0.000154	CcSEcCtD
Topiramate—Oedema—Dexamethasone—psoriasis	0.000115	0.000154	CcSEcCtD
Topiramate—Insomnia—Triamcinolone—psoriasis	0.000115	0.000153	CcSEcCtD
Topiramate—Infection—Betamethasone—psoriasis	0.000114	0.000153	CcSEcCtD
Topiramate—Infection—Dexamethasone—psoriasis	0.000114	0.000153	CcSEcCtD
Topiramate—Ill-defined disorder—Prednisone—psoriasis	0.000114	0.000152	CcSEcCtD
Topiramate—Paraesthesia—Triamcinolone—psoriasis	0.000114	0.000152	CcSEcCtD
Topiramate—Feeling abnormal—Prednisolone—psoriasis	0.000114	0.000152	CcSEcCtD
Topiramate—Visual impairment—Methotrexate—psoriasis	0.000114	0.000152	CcSEcCtD
Topiramate—Anaemia—Prednisone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Shock—Betamethasone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Shock—Dexamethasone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Dyspnoea—Triamcinolone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Nervous system disorder—Dexamethasone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Nervous system disorder—Betamethasone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Agitation—Prednisone—psoriasis	0.000113	0.000151	CcSEcCtD
Topiramate—Thrombocytopenia—Dexamethasone—psoriasis	0.000113	0.00015	CcSEcCtD
Topiramate—Thrombocytopenia—Betamethasone—psoriasis	0.000113	0.00015	CcSEcCtD
Topiramate—Tachycardia—Betamethasone—psoriasis	0.000112	0.00015	CcSEcCtD
Topiramate—Tachycardia—Dexamethasone—psoriasis	0.000112	0.00015	CcSEcCtD
Topiramate—Hypersensitivity—Cyclosporine—psoriasis	0.000112	0.000149	CcSEcCtD
Topiramate—Dyspepsia—Triamcinolone—psoriasis	0.000112	0.000149	CcSEcCtD
Topiramate—Erythema multiforme—Methotrexate—psoriasis	0.000111	0.000149	CcSEcCtD
Topiramate—Nausea—Mycophenolic acid—psoriasis	0.000111	0.000148	CcSEcCtD
Topiramate—Hyperhidrosis—Dexamethasone—psoriasis	0.000111	0.000148	CcSEcCtD
Topiramate—Hyperhidrosis—Betamethasone—psoriasis	0.000111	0.000148	CcSEcCtD
Topiramate—Feeling abnormal—Hydrocortisone—psoriasis	0.000111	0.000148	CcSEcCtD
Topiramate—Malaise—Prednisone—psoriasis	0.000111	0.000148	CcSEcCtD
Topiramate—Vertigo—Prednisone—psoriasis	0.00011	0.000147	CcSEcCtD
Topiramate—Eye disorder—Methotrexate—psoriasis	0.00011	0.000147	CcSEcCtD
Topiramate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00011	0.000147	CcSEcCtD
Topiramate—Syncope—Prednisone—psoriasis	0.00011	0.000147	CcSEcCtD
Topiramate—Tinnitus—Methotrexate—psoriasis	0.00011	0.000147	CcSEcCtD
Topiramate—Anorexia—Dexamethasone—psoriasis	0.00011	0.000146	CcSEcCtD
Topiramate—Anorexia—Betamethasone—psoriasis	0.00011	0.000146	CcSEcCtD
Topiramate—Urticaria—Prednisolone—psoriasis	0.000109	0.000146	CcSEcCtD
Topiramate—Cardiac disorder—Methotrexate—psoriasis	0.000109	0.000146	CcSEcCtD
Topiramate—Fatigue—Triamcinolone—psoriasis	0.000109	0.000146	CcSEcCtD
Topiramate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000109	0.000145	CcSEcCtD
Topiramate—Asthenia—Cyclosporine—psoriasis	0.000109	0.000145	CcSEcCtD
Topiramate—Pain—Triamcinolone—psoriasis	0.000108	0.000145	CcSEcCtD
Topiramate—Loss of consciousness—Prednisone—psoriasis	0.000108	0.000144	CcSEcCtD
Topiramate—Hypotension—Betamethasone—psoriasis	0.000107	0.000143	CcSEcCtD
Topiramate—Hypotension—Dexamethasone—psoriasis	0.000107	0.000143	CcSEcCtD
Topiramate—Pruritus—Cyclosporine—psoriasis	0.000107	0.000143	CcSEcCtD
Topiramate—Urticaria—Hydrocortisone—psoriasis	0.000107	0.000143	CcSEcCtD
Topiramate—Angiopathy—Methotrexate—psoriasis	0.000107	0.000143	CcSEcCtD
Topiramate—Immune system disorder—Methotrexate—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Abdominal pain—Hydrocortisone—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Body temperature increased—Hydrocortisone—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Convulsion—Prednisone—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Mediastinal disorder—Methotrexate—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Asthenia—Mycophenolate mofetil—psoriasis	0.000106	0.000142	CcSEcCtD
Topiramate—Hypertension—Prednisone—psoriasis	0.000106	0.000141	CcSEcCtD
Topiramate—Chills—Methotrexate—psoriasis	0.000106	0.000141	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000105	0.00014	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000105	0.00014	CcSEcCtD
Topiramate—Pruritus—Mycophenolate mofetil—psoriasis	0.000105	0.00014	CcSEcCtD
Topiramate—Myalgia—Prednisone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Arthralgia—Prednisone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Feeling abnormal—Triamcinolone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Anxiety—Prednisone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Alopecia—Methotrexate—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Insomnia—Dexamethasone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Insomnia—Betamethasone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000104	0.000139	CcSEcCtD
Topiramate—Diarrhoea—Cyclosporine—psoriasis	0.000104	0.000138	CcSEcCtD
Topiramate—Paraesthesia—Betamethasone—psoriasis	0.000103	0.000138	CcSEcCtD
Topiramate—Paraesthesia—Dexamethasone—psoriasis	0.000103	0.000138	CcSEcCtD
Topiramate—Discomfort—Prednisone—psoriasis	0.000103	0.000138	CcSEcCtD
Topiramate—Mental disorder—Methotrexate—psoriasis	0.000103	0.000138	CcSEcCtD
Topiramate—Malnutrition—Methotrexate—psoriasis	0.000103	0.000137	CcSEcCtD
Topiramate—Erythema—Methotrexate—psoriasis	0.000103	0.000137	CcSEcCtD
Topiramate—Hypersensitivity—Prednisolone—psoriasis	0.000102	0.000136	CcSEcCtD
Topiramate—Dyspepsia—Betamethasone—psoriasis	0.000101	0.000135	CcSEcCtD
Topiramate—Dyspepsia—Dexamethasone—psoriasis	0.000101	0.000135	CcSEcCtD
Topiramate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000101	0.000135	CcSEcCtD
Topiramate—Urticaria—Triamcinolone—psoriasis	0.000101	0.000134	CcSEcCtD
Topiramate—Dysgeusia—Methotrexate—psoriasis	0.0001	0.000134	CcSEcCtD
Topiramate—Body temperature increased—Triamcinolone—psoriasis	0.0001	0.000134	CcSEcCtD
Topiramate—Dizziness—Cyclosporine—psoriasis	0.0001	0.000134	CcSEcCtD
Topiramate—Oedema—Prednisone—psoriasis	0.0001	0.000134	CcSEcCtD
Topiramate—Decreased appetite—Betamethasone—psoriasis	0.0001	0.000133	CcSEcCtD
Topiramate—Decreased appetite—Dexamethasone—psoriasis	0.0001	0.000133	CcSEcCtD
Topiramate—Infection—Prednisone—psoriasis	9.95e-05	0.000133	CcSEcCtD
Topiramate—Gastrointestinal disorder—Dexamethasone—psoriasis	9.93e-05	0.000133	CcSEcCtD
Topiramate—Gastrointestinal disorder—Betamethasone—psoriasis	9.93e-05	0.000133	CcSEcCtD
Topiramate—Back pain—Methotrexate—psoriasis	9.92e-05	0.000132	CcSEcCtD
Topiramate—Hypersensitivity—Hydrocortisone—psoriasis	9.92e-05	0.000132	CcSEcCtD
Topiramate—Fatigue—Dexamethasone—psoriasis	9.91e-05	0.000132	CcSEcCtD
Topiramate—Fatigue—Betamethasone—psoriasis	9.91e-05	0.000132	CcSEcCtD
Topiramate—Shock—Prednisone—psoriasis	9.85e-05	0.000132	CcSEcCtD
Topiramate—Pain—Betamethasone—psoriasis	9.83e-05	0.000131	CcSEcCtD
Topiramate—Pain—Dexamethasone—psoriasis	9.83e-05	0.000131	CcSEcCtD
Topiramate—Nervous system disorder—Prednisone—psoriasis	9.82e-05	0.000131	CcSEcCtD
Topiramate—Tachycardia—Prednisone—psoriasis	9.77e-05	0.00013	CcSEcCtD
Topiramate—Dizziness—Mycophenolate mofetil—psoriasis	9.77e-05	0.00013	CcSEcCtD
Topiramate—Skin disorder—Prednisone—psoriasis	9.73e-05	0.00013	CcSEcCtD
Topiramate—Hyperhidrosis—Prednisone—psoriasis	9.68e-05	0.000129	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—psoriasis	9.66e-05	0.000129	CcSEcCtD
Topiramate—Asthenia—Hydrocortisone—psoriasis	9.66e-05	0.000129	CcSEcCtD
Topiramate—Vomiting—Cyclosporine—psoriasis	9.63e-05	0.000129	CcSEcCtD
Topiramate—Rash—Cyclosporine—psoriasis	9.55e-05	0.000127	CcSEcCtD
Topiramate—Anorexia—Prednisone—psoriasis	9.55e-05	0.000127	CcSEcCtD
Topiramate—Dermatitis—Cyclosporine—psoriasis	9.54e-05	0.000127	CcSEcCtD
Topiramate—Pruritus—Hydrocortisone—psoriasis	9.52e-05	0.000127	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—psoriasis	9.51e-05	0.000127	CcSEcCtD
Topiramate—Headache—Cyclosporine—psoriasis	9.49e-05	0.000127	CcSEcCtD
Topiramate—Anaemia—Methotrexate—psoriasis	9.48e-05	0.000127	CcSEcCtD
Topiramate—Feeling abnormal—Betamethasone—psoriasis	9.48e-05	0.000127	CcSEcCtD
Topiramate—Feeling abnormal—Dexamethasone—psoriasis	9.48e-05	0.000127	CcSEcCtD
Topiramate—Gastrointestinal pain—Dexamethasone—psoriasis	9.4e-05	0.000126	CcSEcCtD
Topiramate—Gastrointestinal pain—Betamethasone—psoriasis	9.4e-05	0.000126	CcSEcCtD
Topiramate—Vomiting—Mycophenolate mofetil—psoriasis	9.39e-05	0.000125	CcSEcCtD
Topiramate—Hypersensitivity—Triamcinolone—psoriasis	9.34e-05	0.000125	CcSEcCtD
Topiramate—Rash—Mycophenolate mofetil—psoriasis	9.31e-05	0.000124	CcSEcCtD
Topiramate—Dermatitis—Mycophenolate mofetil—psoriasis	9.31e-05	0.000124	CcSEcCtD
Topiramate—Headache—Mycophenolate mofetil—psoriasis	9.25e-05	0.000124	CcSEcCtD
Topiramate—Malaise—Methotrexate—psoriasis	9.25e-05	0.000123	CcSEcCtD
Topiramate—Vertigo—Methotrexate—psoriasis	9.21e-05	0.000123	CcSEcCtD
Topiramate—Diarrhoea—Hydrocortisone—psoriasis	9.21e-05	0.000123	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—psoriasis	9.18e-05	0.000123	CcSEcCtD
Topiramate—Urticaria—Betamethasone—psoriasis	9.13e-05	0.000122	CcSEcCtD
Topiramate—Urticaria—Dexamethasone—psoriasis	9.13e-05	0.000122	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Prednisone—psoriasis	9.12e-05	0.000122	CcSEcCtD
Topiramate—Dizziness—Prednisolone—psoriasis	9.11e-05	0.000122	CcSEcCtD
Topiramate—Asthenia—Triamcinolone—psoriasis	9.09e-05	0.000121	CcSEcCtD
Topiramate—Body temperature increased—Betamethasone—psoriasis	9.09e-05	0.000121	CcSEcCtD
Topiramate—Abdominal pain—Betamethasone—psoriasis	9.09e-05	0.000121	CcSEcCtD
Topiramate—Body temperature increased—Dexamethasone—psoriasis	9.09e-05	0.000121	CcSEcCtD
Topiramate—Abdominal pain—Dexamethasone—psoriasis	9.09e-05	0.000121	CcSEcCtD
Topiramate—Insomnia—Prednisone—psoriasis	9.06e-05	0.000121	CcSEcCtD
Topiramate—Nausea—Cyclosporine—psoriasis	9e-05	0.00012	CcSEcCtD
Topiramate—Paraesthesia—Prednisone—psoriasis	8.99e-05	0.00012	CcSEcCtD
Topiramate—Pruritus—Triamcinolone—psoriasis	8.97e-05	0.00012	CcSEcCtD
Topiramate—Cough—Methotrexate—psoriasis	8.95e-05	0.000119	CcSEcCtD
Topiramate—Dizziness—Hydrocortisone—psoriasis	8.9e-05	0.000119	CcSEcCtD
Topiramate—Convulsion—Methotrexate—psoriasis	8.88e-05	0.000119	CcSEcCtD
Topiramate—Dyspepsia—Prednisone—psoriasis	8.81e-05	0.000118	CcSEcCtD
Topiramate—Nausea—Mycophenolate mofetil—psoriasis	8.77e-05	0.000117	CcSEcCtD
Topiramate—Myalgia—Methotrexate—psoriasis	8.73e-05	0.000117	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—psoriasis	8.73e-05	0.000117	CcSEcCtD
Topiramate—Chest pain—Methotrexate—psoriasis	8.73e-05	0.000117	CcSEcCtD
Topiramate—Decreased appetite—Prednisone—psoriasis	8.7e-05	0.000116	CcSEcCtD
Topiramate—Rash—Prednisolone—psoriasis	8.69e-05	0.000116	CcSEcCtD
Topiramate—Dermatitis—Prednisolone—psoriasis	8.68e-05	0.000116	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8.67e-05	0.000116	CcSEcCtD
Topiramate—Fatigue—Prednisone—psoriasis	8.63e-05	0.000115	CcSEcCtD
Topiramate—Headache—Prednisolone—psoriasis	8.63e-05	0.000115	CcSEcCtD
Topiramate—Discomfort—Methotrexate—psoriasis	8.63e-05	0.000115	CcSEcCtD
Topiramate—Constipation—Prednisone—psoriasis	8.56e-05	0.000114	CcSEcCtD
Topiramate—Vomiting—Hydrocortisone—psoriasis	8.56e-05	0.000114	CcSEcCtD
Topiramate—Rash—Hydrocortisone—psoriasis	8.49e-05	0.000113	CcSEcCtD
Topiramate—Dermatitis—Hydrocortisone—psoriasis	8.48e-05	0.000113	CcSEcCtD
Topiramate—Confusional state—Methotrexate—psoriasis	8.44e-05	0.000113	CcSEcCtD
Topiramate—Headache—Hydrocortisone—psoriasis	8.43e-05	0.000113	CcSEcCtD
Topiramate—Dizziness—Triamcinolone—psoriasis	8.38e-05	0.000112	CcSEcCtD
Topiramate—Infection—Methotrexate—psoriasis	8.31e-05	0.000111	CcSEcCtD
Topiramate—Feeling abnormal—Prednisone—psoriasis	8.25e-05	0.00011	CcSEcCtD
Topiramate—Asthenia—Betamethasone—psoriasis	8.25e-05	0.00011	CcSEcCtD
Topiramate—Asthenia—Dexamethasone—psoriasis	8.25e-05	0.00011	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—psoriasis	8.21e-05	0.00011	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—psoriasis	8.19e-05	0.000109	CcSEcCtD
Topiramate—Gastrointestinal pain—Prednisone—psoriasis	8.19e-05	0.000109	CcSEcCtD
Topiramate—Nausea—Prednisolone—psoriasis	8.19e-05	0.000109	CcSEcCtD
Topiramate—Pruritus—Dexamethasone—psoriasis	8.14e-05	0.000109	CcSEcCtD
Topiramate—Pruritus—Betamethasone—psoriasis	8.14e-05	0.000109	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—psoriasis	8.13e-05	0.000109	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—psoriasis	8.09e-05	0.000108	CcSEcCtD
Topiramate—Vomiting—Triamcinolone—psoriasis	8.06e-05	0.000108	CcSEcCtD
Topiramate—Nausea—Hydrocortisone—psoriasis	7.99e-05	0.000107	CcSEcCtD
Topiramate—Rash—Triamcinolone—psoriasis	7.99e-05	0.000107	CcSEcCtD
Topiramate—Dermatitis—Triamcinolone—psoriasis	7.98e-05	0.000107	CcSEcCtD
Topiramate—Anorexia—Methotrexate—psoriasis	7.98e-05	0.000107	CcSEcCtD
Topiramate—Urticaria—Prednisone—psoriasis	7.96e-05	0.000106	CcSEcCtD
Topiramate—Headache—Triamcinolone—psoriasis	7.94e-05	0.000106	CcSEcCtD
Topiramate—Body temperature increased—Prednisone—psoriasis	7.92e-05	0.000106	CcSEcCtD
Topiramate—Abdominal pain—Prednisone—psoriasis	7.92e-05	0.000106	CcSEcCtD
Topiramate—Diarrhoea—Dexamethasone—psoriasis	7.87e-05	0.000105	CcSEcCtD
Topiramate—Diarrhoea—Betamethasone—psoriasis	7.87e-05	0.000105	CcSEcCtD
Topiramate—Hypotension—Methotrexate—psoriasis	7.82e-05	0.000104	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methotrexate—psoriasis	7.62e-05	0.000102	CcSEcCtD
Topiramate—Dizziness—Betamethasone—psoriasis	7.6e-05	0.000102	CcSEcCtD
Topiramate—Dizziness—Dexamethasone—psoriasis	7.6e-05	0.000102	CcSEcCtD
Topiramate—Insomnia—Methotrexate—psoriasis	7.57e-05	0.000101	CcSEcCtD
Topiramate—Nausea—Triamcinolone—psoriasis	7.53e-05	0.000101	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—psoriasis	7.51e-05	0.0001	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—psoriasis	7.46e-05	9.96e-05	CcSEcCtD
Topiramate—Somnolence—Methotrexate—psoriasis	7.44e-05	9.93e-05	CcSEcCtD
Topiramate—Hypersensitivity—Prednisone—psoriasis	7.38e-05	9.85e-05	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—psoriasis	7.37e-05	9.84e-05	CcSEcCtD
Topiramate—Vomiting—Dexamethasone—psoriasis	7.31e-05	9.76e-05	CcSEcCtD
Topiramate—Vomiting—Betamethasone—psoriasis	7.31e-05	9.76e-05	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—psoriasis	7.27e-05	9.71e-05	CcSEcCtD
Topiramate—Rash—Dexamethasone—psoriasis	7.25e-05	9.68e-05	CcSEcCtD
Topiramate—Rash—Betamethasone—psoriasis	7.25e-05	9.68e-05	CcSEcCtD
Topiramate—Dermatitis—Dexamethasone—psoriasis	7.24e-05	9.67e-05	CcSEcCtD
Topiramate—Dermatitis—Betamethasone—psoriasis	7.24e-05	9.67e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—psoriasis	7.23e-05	9.65e-05	CcSEcCtD
Topiramate—Fatigue—Methotrexate—psoriasis	7.22e-05	9.63e-05	CcSEcCtD
Topiramate—Headache—Dexamethasone—psoriasis	7.2e-05	9.62e-05	CcSEcCtD
Topiramate—Headache—Betamethasone—psoriasis	7.2e-05	9.62e-05	CcSEcCtD
Topiramate—Asthenia—Prednisone—psoriasis	7.18e-05	9.59e-05	CcSEcCtD
Topiramate—Pain—Methotrexate—psoriasis	7.16e-05	9.56e-05	CcSEcCtD
Topiramate—Pruritus—Prednisone—psoriasis	7.08e-05	9.46e-05	CcSEcCtD
Topiramate—Feeling abnormal—Methotrexate—psoriasis	6.9e-05	9.21e-05	CcSEcCtD
Topiramate—Diarrhoea—Prednisone—psoriasis	6.85e-05	9.15e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—psoriasis	6.84e-05	9.14e-05	CcSEcCtD
Topiramate—Nausea—Betamethasone—psoriasis	6.83e-05	9.12e-05	CcSEcCtD
Topiramate—Nausea—Dexamethasone—psoriasis	6.83e-05	9.12e-05	CcSEcCtD
Topiramate—Urticaria—Methotrexate—psoriasis	6.65e-05	8.88e-05	CcSEcCtD
Topiramate—Dizziness—Prednisone—psoriasis	6.62e-05	8.84e-05	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—psoriasis	6.62e-05	8.83e-05	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—psoriasis	6.62e-05	8.83e-05	CcSEcCtD
Topiramate—Vomiting—Prednisone—psoriasis	6.37e-05	8.5e-05	CcSEcCtD
Topiramate—Rash—Prednisone—psoriasis	6.31e-05	8.43e-05	CcSEcCtD
Topiramate—Dermatitis—Prednisone—psoriasis	6.31e-05	8.42e-05	CcSEcCtD
Topiramate—Headache—Prednisone—psoriasis	6.27e-05	8.38e-05	CcSEcCtD
Topiramate—Hypersensitivity—Methotrexate—psoriasis	6.17e-05	8.23e-05	CcSEcCtD
Topiramate—Asthenia—Methotrexate—psoriasis	6e-05	8.02e-05	CcSEcCtD
Topiramate—Nausea—Prednisone—psoriasis	5.95e-05	7.94e-05	CcSEcCtD
Topiramate—Pruritus—Methotrexate—psoriasis	5.92e-05	7.91e-05	CcSEcCtD
Topiramate—Diarrhoea—Methotrexate—psoriasis	5.73e-05	7.65e-05	CcSEcCtD
Topiramate—Dizziness—Methotrexate—psoriasis	5.53e-05	7.39e-05	CcSEcCtD
Topiramate—Vomiting—Methotrexate—psoriasis	5.32e-05	7.1e-05	CcSEcCtD
Topiramate—Rash—Methotrexate—psoriasis	5.28e-05	7.05e-05	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—psoriasis	5.27e-05	7.04e-05	CcSEcCtD
Topiramate—Headache—Methotrexate—psoriasis	5.24e-05	7e-05	CcSEcCtD
Topiramate—Nausea—Methotrexate—psoriasis	4.97e-05	6.64e-05	CcSEcCtD
